Your browser is no longer supported. Please, upgrade your browser.
SCPH scPharmaceuticals Inc. daily Stock Chart
scPharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.66 Insider Own0.10% Shs Outstand20.22M Perf Week6.56%
Market Cap201.89M Forward P/E- EPS next Y-1.91 Insider Trans- Shs Float7.16M Perf Month0.53%
Income-31.40M PEG- EPS next Q-0.43 Inst Own55.50% Short Float3.06% Perf Quarter-13.98%
Sales- P/S- EPS this Y-11.80% Inst Trans15.07% Short Ratio1.59 Perf Half Y30.43%
Book/sh2.73 P/B2.79 EPS next Y-5.60% ROA-38.30% Target Price13.33 Perf Year111.36%
Cash/sh2.85 P/C2.68 EPS next 5Y- ROE-55.10% 52W Range3.55 - 11.99 Perf YTD34.81%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-36.36% Beta-
Dividend %- Quick Ratio17.00 Sales past 5Y- Gross Margin- 52W Low114.93% ATR0.66
Employees15 Current Ratio17.00 Sales Q/Q- Oper. Margin- RSI (14)46.32 Volatility8.90% 9.68%
OptionableNo Debt/Eq0.00 EPS Q/Q25.40% Profit Margin- Rel Volume0.45 Prev Close7.55
ShortableYes LT Debt/Eq0.34 EarningsMay 12 BMO Payout- Avg Volume137.80K Price7.63
Recom2.00 SMA201.90% SMA50-11.52% SMA2008.49% Volume61,329 Change1.13%
Oct-15-19Initiated H.C. Wainwright Buy $13
Jan-30-19Downgrade Leerink Partners Outperform → Mkt Perform
Jul-10-20 08:00AM  
Jul-01-20 08:00AM  
Jun-23-20 10:50AM  
Jun-18-20 08:00AM  
Jun-12-20 12:28PM  
May-28-20 08:00AM  
May-21-20 02:20PM  
May-20-20 11:18PM  
May-12-20 07:00AM  
Mar-24-20 07:00AM  
Feb-26-20 08:00AM  
Feb-20-20 08:00AM  
Jan-22-20 10:14AM  
Dec-21-19 07:10PM  
Dec-12-19 08:00AM  
Nov-26-19 08:00AM  
Nov-22-19 07:15AM  
Nov-14-19 08:00AM  
Nov-12-19 08:00AM  
Sep-18-19 08:00AM  
Aug-07-19 08:00AM  
Aug-06-19 08:00AM  
Jul-26-19 09:32AM  
May-30-19 08:00AM  
May-08-19 08:00AM  
Apr-27-19 10:46AM  
Mar-21-19 08:00AM  
Feb-21-19 08:00AM  
Jan-29-19 08:00AM  
Nov-21-18 08:40AM  
Nov-13-18 08:00AM  
Oct-18-18 07:30AM  
Aug-14-18 08:00AM  
Jul-24-18 08:00AM  
Jun-28-18 08:00AM  
Jun-13-18 08:51AM  
May-31-18 02:26PM  
May-30-18 08:00AM  
May-07-18 04:01PM  
Apr-30-18 10:54AM  
Apr-11-18 08:00AM  
Apr-04-18 09:05AM  
Mar-20-18 07:22PM  
Mar-01-18 08:00AM  
Feb-06-18 08:00AM  
Dec-20-17 11:06AM  
Dec-12-17 08:00AM  
Nov-29-17 09:23AM  
Nov-27-17 02:45PM  
Nov-16-17 09:05PM  
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schwab Andrew J.10% OwnerMay 26Buy8.65578,0344,999,994578,034May 28 09:12 PM
ORBIMED ADVISORS LLC10% OwnerMay 21Buy8.651,387,28311,999,9984,565,948May 26 04:44 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerFeb 14Buy8.20271,9932,230,3433,247,005Feb 19 04:30 PM
Tucker John HPresident and CEODec 13Buy5.245,00026,1895,000Dec 17 04:16 PM